MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-23
DOI
10.1186/s13045-019-0793-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma
- (2018) Xiao-Yan Lin et al. CHINESE MEDICAL JOURNAL
- Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
- (2018) Stefan Kiesgen et al. Journal of Thoracic Oncology
- Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells
- (2018) Venugopal Vinod Prabhu et al. GENE
- Study on the mechanism of excessive apoptosis of nucleus pulposus cells induced by shRNA-Piezo1 under abnormal mechanical stretch stress
- (2018) Qining Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
- (2018) Sijia Huang et al. mAbs
- Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bi-targeted Chimeric Antigen Receptor T Cell
- (2018) Hua Jiang et al. Cancer Immunology Research
- CAR T-cell therapy of solid tumors
- (2017) Carmen S M Yong et al. IMMUNOLOGY AND CELL BIOLOGY
- Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities
- (2017) Anja Wegner Immunotherapy
- Chimeric antigen receptor transduced T cells: Tuning up for the next generation
- (2017) Maria-Luisa Schubert et al. INTERNATIONAL JOURNAL OF CANCER
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells
- (2017) J Zhao et al. ONCOGENE
- CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells
- (2017) Q Wang et al. ONCOGENE
- MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients
- (2017) Yishui Lian et al. PATHOLOGY RESEARCH AND PRACTICE
- CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
- (2017) Masha Zeltsman et al. Translational Research
- Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer
- (2017) Naohiko Koshikawa et al. Cell Death & Disease
- Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer
- (2017) Xinfeng Chen et al. Oncology Letters
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Association of MAGE A1-6 Expression with Lung Cancer Progression
- (2017) Eunjue Yi et al. Journal of Cancer
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model
- (2017) Elham Pishali Bejestani et al. OncoImmunology
- CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
- (2017) Thivyan Thayaparan et al. OncoImmunology
- Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
- (2017) Irene Scarfò et al. Journal for ImmunoTherapy of Cancer
- Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
- (2017) J. Gauthier et al. Current Research in Translational Medicine
- MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation
- (2016) Dong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FBXW7is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors
- (2016) Shoko Kitade et al. CANCER SCIENCE
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer
- (2016) Ingo Mecklenburg et al. CLINICAL CANCER RESEARCH
- MAGE-A1–6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes
- (2016) Sang Tae Noh et al. International Journal of Clinical Oncology
- MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray
- (2016) Meixiang Sang et al. JOURNAL OF CLINICAL PATHOLOGY
- MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases
- (2016) Sid P. Kerkar et al. JOURNAL OF IMMUNOTHERAPY
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Versatile strategy for controlling the specificity and activity of engineered T cells
- (2016) Jennifer S. Y. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types
- (2016) Cheng Wang et al. Nature Communications
- GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
- (2016) Michael S. Magee et al. OncoImmunology
- Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
- (2015) Carlos T. Pineda et al. CELL
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer
- (2015) Jean-Louis Pujol et al. Journal of Thoracic Oncology
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
- (2015) Nesaretnam Barr Kumarakulasinghe et al. RESPIROLOGY
- MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
- (2015) Lynnette Marcar et al. PLoS One
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
- (2014) Xuefeng Gu et al. Scientific Reports
- Selection and Characterization of Human Anti-MAGE-A1 scFv and Immunotoxin
- (2013) Hong Lin et al. Anti-Cancer Agents in Medicinal Chemistry
- Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer
- (2013) Xin Yang et al. CANCER LETTERS
- A novel human Fab antibody for Trop2 inhibits breast cancer growthin vitroandin vivo
- (2013) Hong Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
- (2013) V. D. Fedorov et al. Science Translational Medicine
- Immunological monitoring of anticancer vaccines in clinical trials
- (2013) Chizuru Ogi et al. OncoImmunology
- Tumor-specific MAGE proteins as regulators of p53 function
- (2012) María Fátima Ladelfa et al. CANCER LETTERS
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells
- (2011) Masaki Kimura et al. CANCER SCIENCE
- Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
- (2010) L. Marcar et al. CANCER RESEARCH
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
- (2009) Robert H Kutner et al. Nature Protocols
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now